Efficacy and safety of interferon alpha-2b versus pegylated interferon alpha-2a monotherapy in children with chronic hepatitis B: a real-life cohort study from Shanghai, China

被引:0
作者
Yao Hu
Ying-Zi Ye
Li-Jing Ye
Xiao-Hong Wang
Hui Yu
机构
[1] Children’s Hospital of Fudan University,Department of Infectious Diseases
来源
World Journal of Pediatrics | 2019年 / 15卷
关键词
Antiviral therapy; Children; Chronic hepatitis B; Interferon alpha; Pegylated interferon alpha;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:595 / 600
页数:5
相关论文
共 119 条
[1]  
Ott JJ(2012)Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity Vaccine 30 2212-2219
[2]  
Stevens GA(2012)Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010 Lancet 380 2095-2128
[3]  
Groeger J(2015)Guidelines for treatment of chronic hepatitis B (2015) Chin J of Exp Clinic Infect Dis (Electron Ed) 33 570-589
[4]  
Wiersma ST(2016)AASLD guidelines for treatment of chronic hepatitis B Hepatology 63 261-283
[5]  
Lozano R(2017)EASL Clinical practice guidelines on the management of hepatitis B virus infection J Hepatol 2017 370-398
[6]  
Naghavi M(2010)Treatment of children with chronic hepatitis B virus infection in the United States: patient selection and therapeutic options Hepatology 52 2192-2205
[7]  
Foreman K(2013)Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines: consensus of an expert panel on behalf of the European society of pediatric gastroenterology Hepatology and Nutrition J Hepatol 59 814-829
[8]  
Lim S(2009)Management of chronic hepatitis B in children J Pediatr Gastroenter and Nutr 48 399-404
[9]  
Shibuya K(2012)Chronic hepatitis B in children and adolescents J Hepatol 57 885-896
[10]  
Aboyans V(2018)Update on prevention, diagnosis, and treatment and of chronic hepatitis B: AASLD 2018 hepatitis B guidance Hepatology 67 1560-1599